SCHEMBL21754792

SCHEMBL21754792

Cc1ccc(C(=O)OC[C@H]2OC(C)[C@@H](F)[C@@H]2OC(=O)c2ccc(C)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.46
PTPN1 P18031 4/20 0.46
LGALS3 P17931 3/20 0.46
LGALS9 O00182 1/20 0.46
LGALS1 P09382 1/20 0.46
F11 P03951 2/20 0.40
USP2 O75604 2/20 0.39
MEN1 O00255 1/20 0.39
POLB P06746 1/20 0.39
KMT2A Q03164 1/20 0.39
PTPN2 P17706 1/20 0.39
PTPN11 Q06124 1/20 0.39
ELANE P08246 1/20 0.39
RAB9A P51151 3/20 0.38
NPC1 O15118 2/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.38
TMPRSS2 O15393 1/20 0.38
PDE5A O76074 1/20 0.38
CA1 P00915 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21754796 0.89 UPP1 (0.48) HPGDPTPN1F11USP2MEN1
SCHEMBL25509971 0.89 POLB (0.49) PTPN1LGALS3LGALS9LGALS1F11
SCHEMBL14931047 0.89 POLB (0.49) PTPN1LGALS3LGALS9LGALS1F11
SCHEMBL25510429 0.89 POLB (0.49) PTPN1LGALS3LGALS9LGALS1F11
SCHEMBL16926957 0.89 POLB (0.49) PTPN1LGALS3LGALS9LGALS1F11
SCHEMBL14208949 0.89 POLB (0.49) PTPN1LGALS3LGALS9LGALS1F11
SCHEMBL26291341 0.89 POLB (0.49) PTPN1LGALS3LGALS9LGALS1F11
SCHEMBL8389853 0.89 POLB (0.49) PTPN1LGALS3LGALS9LGALS1F11
SCHEMBL19841658 0.88 PTPN1 (0.52) HPGDPTPN1LGALS3LGALS9LGALS1
SCHEMBL21754762 0.88 PTPN1 (0.45) PTPN1F11USP2MEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10570112-B2 Synthetic intermediate of 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)cytosine, synthetic intermediate of thionucleoside, and method for producing the same FUJIFILM CORPORATION (JP) 2020-02-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10570112-B2 Synthetic intermediate of 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)cytosine, synthetic intermediate of thionucleoside, and method for producing the same TYMS, TYMP, RRM2B HPGD 2710/4885PTPN1 4173/4885LGALS3 3025/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.